New 2019 National Psoriasis Foundation Symposium

Focuses on The Future of Psoriatic Disease: Prevention, Precision Medicine & Cure

Portland, Ore. (December 11, 2018)—The National Psoriasis Foundation, NPF, announces the opening of registration for The Future of Psoriatic Disease: Prevention, Precision Medicine & Cure. The two-day symposium will take place in Seattle, Washington on May 30-31, 2019 at the Hyatt Regency Seattle.

Psoriatic disease is a heterogeneous immune-mediated disease affecting the skin, the joints, and other organ systems. The symposium provides a unique opportunity for experts across disciplines to come together with each other to advance research in the field.

Co-chaired by members of the NPF Scientific Advisory Committee, Wilson Liao, MD, Director of the UCSF Psoriasis Center, Associate Professor in Residence in Dermatology, and Johann Gudjonsson, MD, Ph.D., Assistant Professor; University of Michigan Department of Dermatology, the 2019 symposium will introduce a new approach to developing a scientific roadmap to achieve prevention, precision medicine, and a cure for psoriatic diseases. The symposium will provide a venue for education, dissemination of scientific results, and collaboration between clinicians and scientists.

The two-day symposium kicks off with a keynote titled the “Immunologic Insights into Psoriasis” by one of the world’s leading experts on the role of resident memory T cells in health and disease, Rachael Clark, MD, Ph.D. Dr. Clark is the Shing-Yiu Yip and Cecilia M. Hepp Associate Professor of Dermatology, Harvard Medical School and Associate Dermatologist, Brigham and Women’s Hospital.

The symposium will offer four plenary sessions titled, Prevention Strategies in Psoriatic Disease and Co-Morbidities, Heterogeneity of Psoriatic Disease and Precision Medicine, Towards a Psoriatic Cure, and Lessons Learned from Cure Initiatives. Attendees will also rotate through three breakout sessions titled: Clinical/Scientific Gaps in Knowledge & How to Address, Cure Definitions, Milestones, & Biomarkers, and Propose Cure Working Groups and Cure Organizational Roadmap.

Interested attendees may submit an abstract to share original research to be considered for either a poster or oral presentation. Travel grants are available for a select number of trainees or early stage investigators. Abstract and travel grant requests must be submitted no later than March 6, 2019. For more information, visit

For registration or symposium information, visit


About the National Psoriasis Foundation

Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $21 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at